Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PAD4 inhibitors(peptidyl arginine deiminase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Regor Therapeutics GroupStartup |
Active Organization Regor Therapeutics GroupStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | CN | Regor Therapeutics GroupStartup | 12 Nov 2023 |
Inflammation | Preclinical | CN | Regor Therapeutics GroupStartup | 12 Nov 2023 |